X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

期刊標題檢索 J CELL MOL MED 最新評論: Editors and reviewers are very responsible, and accepted our paper as ... (2016-09-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CELLULAR AND MOLECULAR MEDICINE]您好,您是該頁面的第 78945 位訪客。

期刊簡介
期刊名稱JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LetPub Score
7.5
50 ratings
Rate

Reputation
8.3

Influence
6.6

Speed
9.4

期刊簡稱J CELL MOL MED
ISSN1582-4934
h-index108
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.501.2070.917
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q127 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q146 / 285

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934
在線稿件提交https://mc.manuscriptcentral.com/jcmm
開放訪問Yes
出版商Wiley-Blackwell Publishing Ltd
主題領域CELL BIOLOGY
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數403每年文章數趨勢
黃金OA百分比65.76%
OA Related Info
APC: Yes( USD4510; GBP2920; EUR4180; )
APC waiver:Check Notes
Other charges: No
Keywords: cellular medicine、molecular medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ281/205
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ258/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1582-4934%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 28 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【JOURNAL OF CELLULAR AND MOLECULAR MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science Translational MedicineH-index: 168

    CiteScore: 26.70
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    Wiley Interdisciplinary Reviews-Nanomedicine and NanobiotechnologyH-index: 0

    CiteScore: 17.60
    EXPERT REVIEWS IN MOLECULAR MEDICINEH-index: 73

    CiteScore: 7.40
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    American Journal of Translational ResearchH-index: 45

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International398129
    Science Translational Medicine170707
    American Journal of Translational Research165370
    Stem Cell Research & Therapy136208
    Frontiers of Medicine89266
    Journal of Diabetes Research56540
    Journal of Cardiovascular Translational Research32186
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology30807
    EXPERT REVIEWS IN MOLECULAR MEDICINE17238
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION16000
  •  

    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論撰寫評論
作者: Anonymous


領域: 生命科学
審稿時間: 2.0 month(s)
結果: 直接被接受


撰寫評論

2016-09-01 21:47:05 評論於
Editors and reviewers are very responsible, and accepted our paper as is. The publication fee is quite expensive. Overall it was all good.

(1) 讚! | Anonymous

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*